awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36843902-E0D2E8AB-4F4E-4C53-A0E8-78606B1FBBF2
Q36843902-E0D2E8AB-4F4E-4C53-A0E8-78606B1FBBF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36843902-E0D2E8AB-4F4E-4C53-A0E8-78606B1FBBF2
Efficacy, safety, and tolerability of ipragliflozin in Asian patients with type 2 diabetes mellitus and inadequate glycemic control with metformin: Results of a phase 3 randomized, placebo-controlled, double-blind, multicenter trial.
P2860
Q36843902-E0D2E8AB-4F4E-4C53-A0E8-78606B1FBBF2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36843902-E0D2E8AB-4F4E-4C53-A0E8-78606B1FBBF2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47bdd32a687cd73dd8f3c6e351fe97a75fffa852
P2860
Randomized, placebo-controlled, double-blind glycemic control trial of novel sodium-dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus